Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome

Terry J Quinn* (Corresponding Author), Phyo K Myint, Jenny McCleery, Martin Taylor-Rowan, Carrie Stewart

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

This is a protocol for a Cochrane Review (Prognosis). The objectives are as follows:

Primary objective: to assess whether ACB in older adults is a prognostic factor for future cognitive decline or dementia.

Secondary objective(s): to assess whether ACB is a prognostic factor for older adults recruited in primary care, secondary care, or community settings (with setting used as the basis for subgroup analyses); whether ACB is associated with mortality; to compare the prognostic validity of respective ACB scales; and to examine the effect of duration of exposure and duration of follow‐up on the ACB‐dementia risk association.
Original languageEnglish
Article numberCD013540
Number of pages13
JournalCochrane Database of Systematic Reviews
Issue number2
DOIs
Publication statusPublished - 18 Feb 2020

Fingerprint

Dive into the research topics of 'Anticholinergic burden (prognostic factor) for prediction of dementia or cognitive decline in older adults with no known cognitive syndrome'. Together they form a unique fingerprint.

Cite this